0000899243-15-005211.txt : 20150922
0000899243-15-005211.hdr.sgml : 20150922
20150922173019
ACCESSION NUMBER: 0000899243-15-005211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150922
FILED AS OF DATE: 20150922
DATE AS OF CHANGE: 20150922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENXBIO Inc.
CENTRAL INDEX KEY: 0001590877
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-552-8181
MAIL ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: REGENXBIO, Inc.
DATE OF NAME CHANGE: 20150116
FORMER COMPANY:
FORMER CONFORMED NAME: ReGenX Biosciences, LLC
DATE OF NAME CHANGE: 20131101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Allan M.
CENTRAL INDEX KEY: 0001652936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37553
FILM NUMBER: 151119937
MAIL ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-22
0
0001590877
REGENXBIO Inc.
RGNX
0001652936
Fox Allan M.
C/O REGENXBIO INC.
9712 MEDICAL CENTER DRIVE, SUITE 100
ROCKVILLE
MD
20850
1
0
1
0
Common Stock
2015-09-22
4
C
0
722485
A
722485
I
See Footnote
Common Stock
2015-09-22
4
C
0
722485
A
722485
I
See Footnote
Common Stock
2015-09-22
4
C
0
853915
A
1576400
I
See Footnote
Common Stock
2015-09-22
4
C
0
478463
A
2054863
I
See Footnote
Common Stock
443700
I
See Footnote
Series A Preferred Stock
2015-09-22
4
C
0
722485
0.00
D
Common Stock
722485
0
I
See Footnote
Series A Preferred Stock
2015-09-22
4
C
0
722485
0.00
D
Common Stock
722485
0
I
See Footnote
Series B Preferred Stock
2015-09-22
4
C
0
853915
0.00
D
Common Stock
853915
0
I
See Footnote
Series C Preferred Stock
2015-09-22
4
C
0
478463
0.00
D
Common Stock
478463
0
I
See Footnote
Each share of Preferred Series A, Preferred Series B, and Preferred Series C Stock is convertible and will automatically convert on a 1:1 basis into the Issuer's common stock upon the closing of the Issuer's initial public offering of common stock pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. These shares have no expiration date.
The Reporting Person is a trustee of The Allan M. Fox Trust (U/A/D April 21, 2015), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise or such portion of the shares of common stock of the Issuer held by The Allan M. Fox Trust (U/A/D April 21, 2015), in which the Reporting Person has no pecuniary interest.
The Reporting Person is a trustee of The Allan M. Fox Revocable Trust, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise or such portion of the shares of common stock of the Issuer held by The Allan M. Fox Revocable Trust, in which the Reporting Person has no pecuniary interest.
The Reporting Person holds shared dispositive power over the shares held by FoxKiser Holdings, LLC with John Daniel Kiser, with the Reporting Person having a 60% voting interest in FoxKiser Holdings, LLC.
/s/ Allan M. Fox
2015-09-22